——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information Wien (euro adhoc) – – » Indian authorities granted approval for Japanese Encephalitis (JE) vaccine in endemic region » Important milestone towards introduction of Intercell´s modern, cell culture-derived technology based vaccine in endemic countries [...]
Tag Archive > Cell Culture
EANS-Adhoc: Intercell AG / Intercell and Biological E. Ltd. announce successful completion of investigational Japanese Encephalitis vaccine pivotal Phase II/III study in India
——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Research & Development 16.09.2011 * Positive results from first pivotal immunogenicity Phase II/III trial in endemic region to prevent Japanese Encephalitis (JE) in children * Primary study endpoint of [...]
EANS-News: Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanese Encephalitis
- » First Phase III trial towards pediatric label extension for IXIARO®/JESPECT® preventing Japanese Encephalitis (JE) in travelers to endemic countries » Important development step towards making IXIARO/JESPECT available to children ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research & Development Subtitle: – [...]
InVitria Reveals Technology to Optimize Hybridoma Production Performance
(pressebox) Fort Collins, 27.04.2009, Recent studies using both classical media and the leading commercial serum-free hybridoma media formulations proved that InVitria’s cell culture supplements optimized cell growth and productivity of hybridoma cells. 1 Further, the studies revealed that Cellastim supports cell adaptation and survival in chemically-defined media. Additional findings from the study showed that Cellastim [...]
VITROCELL® presented turnkey in vitro test systems for nano particles, gases and complex mixtures at the 2009 SOT Annual Meeting in Baltimore.
(pressebox) Waldkirch, 04.04.2009, The 2009 SOT Conference from March 15-19, 2009 in Baltimore/USA was again a successful SOT Annual Meeting and ToxExpo. Attendance was remarkably strong this year with a grand total of 6,750 registrants. The final number of abstracts presented was 2,322. VITROCELL® SYSTEMS participated in the ToxExpo exhibition showing its broad product program [...]
Roche Completes xCELLigence Family of Products with the New, Highly Flexible xCELLigence RTCA DP Instrument
(pressebox) Penzberg, 01.04.2009, Following the launches of the xCELLigence RTCA SP Instrument and the RTCA MP Instrument last year, Roche Applied Science has now completed its xCELLigence Real-Time Cell Analyzer product line with its newest model, the RTCA DP Instrument. The xCELLigence system measures impedance-based signals both in label-free cellular analysis and in cell invasion/migration [...]
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
Maidenhead, England (ots/PRNewswire) – – Improvements in Purification Process Represent Important Advance in the Treatment of Haemophilia A Wyeth announced today it has received a positive decision from the European Commission for a variation of the marketing authorisation for ReFacto moroctocog alfa (Recombinant Coagulation Factor VIII), a treatment for haemophilia A. The manufacturing process for [...]
